Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cellectar Biosc (CLRB)

Cellectar Biosc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cellectar Biosc 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 USA

www.cellectar.com P: 608-441-8120 F: 608-441-8121

Description:

Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.

Key Statistics

Overview:

Market Capitalization, $K 98,719
Enterprise Value, $K 95,219
Shares Outstanding, K 32,261
Annual Sales, $ 0 K
Annual Net Income, $ -37,980 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,450 K
EBIT, $ -38,960 K
EBITDA, $ -38,770 K
60-Month Beta 0.92
% of Insider Shareholders 4.60%
% of Institutional Shareholders 16.41%
Float, K 30,777
% Float 95.40%
Short Volume Ratio 0.43

Growth:

1-Year Return 103.38%
3-Year Return -80.63%
5-Year Return -87.36%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 93.24%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.66 on 03/27/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -2.97
EPS Growth vs. Prev Qtr 19.51%
EPS Growth vs. Prev Year -20.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/22/22

CLRB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -280.23%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.07
Interest Coverage -2.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar